FTSJ1
protein-codingFtsJ RNA 2'-O-methyltransferase 1, the group of 7BS 2'O-ribose DNA/RNA methyltransferases
Gene summary
This gene encodes a member of the methyltransferase superfamily. The encoded protein localizes to the nucleolus, binds to S-adenosylmethionine, and may be involved in the processing and modification of ribosomal RNA. Mutations in this gene are associated with cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
- MRX9
- MRX44
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~10.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: XL
Disease ID:MONDO:0010660
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: XL
Disease ID:MONDO:0010660
Submitter: G2P
Inheritance Pattern: XL
Disease ID:MONDO:0100148
Submitter: ClinGen
The *FTSJ1* gene is a member of the methyltransferase superfamily involved in the processing and modification of ribosomal RNA. *FTSJ1* was first reported in relation to X-linked complex neurodevelopmental disorder in 2004 by Freude *et al*. (PMID: 15162322) who reported loss-of-function variants in two multigenerational families with several affected males and one male proband with non-syndromic intellectual disability. At least 9 variants have been reported, including 5 splice-site, 2 nonsense, 1 frameshift, and 1 missense variant with altered protein function (PMIDs: 15162322, 15342698, 18081026, 26310293, 31170314, 31981491, 36720500). Of note, missense variants without functional characterization were of unclear pathogenicity and were not scored (PMIDs: 25644381, 28330790). Segregation evidence is available from three families with more than three affected members each (PMIDs: 15162322, 15342698). Affected males exhibit mild to moderate intellectual disability and behavior problems, including autism spectrum disorder in some; at least two individuals had seizures or abnormal EEG. Carrier females are unaffected. This gene-disease relationship is also supported by experimental evidence, including biochemical function (PMID: 304115557), functional alteration in patient cells (PMID: 26310293), and mouse models (PMIDs: 30557699, 33771871). In summary, there is definitive evidence supporting the relationship between *FTSJ1* and X-linked complex neurodevelopmental disorder. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on February 1, 2023 (SOP Version 9). This gene-disease pair was originally evaluated on January 17, 2018 and classified as moderate. Curation of additional genetic and experimental evidence resulted in the classification being updated.
Inheritance Pattern: XL
Disease ID:MONDO:0019181
Submitter: Orphanet
Inheritance Pattern: XL
Disease ID:MONDO:0010660
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to FTSJ1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_012280.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 8 | 20 | 3 | 31 | ||
| missense | 2 | 3 | 61 | 10 | 3 | 79 |
| nonsense | 1 | 1 | 2 | |||
| start loss | 1 | 1 | ||||
| frameshift | 5 | 1 | 1 | 7 | ||
| splice donor/acceptor (+/-2bp) | 2 | 1 | 11 | 14 | ||
| Total | 10 | 6 | 82 | 30 | 6 | 134 |
Highest pathogenic variant AF is 0.000009077705
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_036412.1 | 11 | MANE Select | |
| Ensembl | ENSP00000326948.2 | 11 | MANE Select | |
| RefSeq | NP_001269086.1 | 7 | Standard | |
| RefSeq | NP_001428124.1 | 11 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- tRNA modification in the nucleus and cytosol
- tRNA processing
- Metabolism of RNA
Biological Process
- tRNA nucleoside ribose methylation
- cytoplasmic translation
- tRNA modification
- tRNA methylation
Molecular Function
- tRNA methyltransferase activity
- tRNA (guanosine-2'-O-)-methyltransferase activity
- tRNA (cytosine-2'-O-)-methyltransferase activity
Cellular Component
- cytoplasm
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000348411
- Coding exons
- 11
- Length
- 10212
- Individuals with no LoFs
- 0
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 0
- Defined
- 0
- p
- 0.00
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.17 | 73 | 147 | 0.496 | 0.0000126 | 2137 |
| Missense (PolyPhen) | 8 | 51.464 | 0.15545 | 703 | ||
| Synonymous | 0.460 | 55 | 59.5 | 0.924 | 0.00000504 | 659 |
| Loss of Function | 3.54 | 0 | 14.6 | 0.00 | 0.00000109 | 221 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Methylates the 2'-O-ribose of nucleotides at positions 32 and 34 of the tRNA anticodon loop of substrate tRNAs. {ECO:0000255|HAMAP-Rule:MF_03162}.;
Recessive Scores
- pRec
- 0.177
Intolerance Scores
- RVIS EVS
- -0.01
- RVIS percentile EVS
- 53.51
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.539
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |